- ►annals.org [PDF] L Sung, PC Nathan, SMH Alibhai, GA … - Annals of Internal Medicine, 2007 - Am Coll Physicians Background: Benefits of prophylactic hematopoietic colony-stimu- lating factors
(CSFs) in adults and children receiving cancer chemo- therapy or undergoing
stem-cell transplantation (SCT) are unclear. ... Purpose: To determine ... Cited by 20 - Related articles - BL Direct - All 4 versions
CT Kouroukis, S Chia, S Verma, D Robson, C … - Current Oncology, 2008 - pubmedcentral.nih.gov Hematologic toxicities of cancer chemotherapy are common and often limit the
ability to provide treatment in a timely and dose-intensive manner. These
limitations may be of utmost importance in the adjuvant and curative intent ... Cited by 3 - Related articles - BL Direct - All 7 versions
N Schmitz, P Ljungman, C Cordonnier, C Kempf … - Bone Marrow Transplantation, 2004 - nature.com A phase III, randomized, double-blind, placebo-controlled, multi-center trial
was conducted in order to compare the incidence of microbiologically defined
infections occurring after high-dose chemotherapy (HDT) and ASCT in 98 ... Cited by 20 - Related articles - BL Direct - All 4 versions
V Erard, A Wald, L Corey, WM Leisenring, M … - The Journal of infectious diseases, 2007 - UChicago Press Featured in Reuters "Eye study shows how deadly form of malaria kills" January
15, 2009 Perfusion Abnormalities in Children with Cerebral Malaria and Malarial
Retinopathy Nicholas AV Beare, Simon P. Harding, Terrie E. Taylor, Susan ... Cited by 10 - Related articles - BL Direct - All 5 versions
- ►jcojournal.org [PDF] NM Kuderer, DC Dale, J Crawford, GH Lyman - Journal of Clinical Oncology, 2007 - jcojournal.org Page 1. Impact of Primary Prophylaxis With Granulocyte Colony- Stimulating
Factor on Febrile Neutropenia and Mortality in Adult Cancer ... Cited by 64 - Related articles - BL Direct - All 8 versions
C Burton, D Linch, P Hoskin, D Milligan, … - British journal of cancer, 2006 - nature.com The management of older patients with aggressive non-Hodgkin's lymphoma presents
a challenge to the physician. Age is a poor prognostic indicator, due to reduced
ability to tolerate and maintain dose-intensive chemotherapy. Generally, ... Cited by 11 - Related articles - BL Direct - All 7 versions
- ►ascopubs.org [PDF] E Robenshtok, A Gafter-Gvili, E Goldberg, M … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org Purpose To evaluate the effect of antifungal prophylaxis on all-cause mortality
as primary outcome, invasive fungal infections (IFIs), and adverse events. Many
studies have evaluated the role of antifungal prophylaxis in cancer ... Cited by 34 - Related articles - All 10 versions
[CITATION] Successful bone marrow/stem cell transplantation in patients with previous Aspergillus …
T Lange, D Wolff, T Skibbe… - 25th Annual Meeting European group for Blood and …, 1999 Cited by 2 - Related articles
M Bitan - Clinical Infectious Diseases, 2006 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 2 - Related articles - BL Direct - All 3 versions
SJ Noga, JK Choksi, B Ding, L Dreiling, H … - Clinical lymphoma & myeloma, 2007 - CIG Media Group Introduction Each year, > 70,000 patients in the United States are diagnosed
with lymphoma.1 In the past 25 years, significant improvements have been made in
relative 5-year survival rates for Hodgkin Cited by 2 - Related articles - BL Direct - All 3 versions
